ES2279395T3 - Pirimidinas 2-substituidas. - Google Patents

Pirimidinas 2-substituidas. Download PDF

Info

Publication number
ES2279395T3
ES2279395T3 ES04741053T ES04741053T ES2279395T3 ES 2279395 T3 ES2279395 T3 ES 2279395T3 ES 04741053 T ES04741053 T ES 04741053T ES 04741053 T ES04741053 T ES 04741053T ES 2279395 T3 ES2279395 T3 ES 2279395T3
Authority
ES
Spain
Prior art keywords
carbon atoms
formula
atoms
carbon
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES04741053T
Other languages
English (en)
Spanish (es)
Inventor
Anja Schwogler
Markus Gewehr
Bernd Muller
Thomas Grote
Wassilios Grammenos
Jordi Tormo I Blasco
Andreas Gypser
Joachim Rheinheimer
Carsten Blettner
Peter Schafer
Frank Schieweck
Oliver Wagner
Reinhard Stierl
Ulrich Schofl
Siegfried Strathmann
Maria Scherer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Application granted granted Critical
Publication of ES2279395T3 publication Critical patent/ES2279395T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES04741053T 2003-07-24 2004-07-15 Pirimidinas 2-substituidas. Expired - Lifetime ES2279395T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE10333857 2003-07-24
DE10333857 2003-07-24
DE10357714 2003-12-09
DE10357714 2003-12-09

Publications (1)

Publication Number Publication Date
ES2279395T3 true ES2279395T3 (es) 2007-08-16

Family

ID=34117367

Family Applications (1)

Application Number Title Priority Date Filing Date
ES04741053T Expired - Lifetime ES2279395T3 (es) 2003-07-24 2004-07-15 Pirimidinas 2-substituidas.

Country Status (30)

Country Link
US (1) US7375108B2 (https=)
EP (1) EP1651618B1 (https=)
JP (1) JP2006528603A (https=)
KR (1) KR20060052857A (https=)
AP (1) AP2157A (https=)
AR (1) AR045100A1 (https=)
AT (1) ATE350370T1 (https=)
AU (1) AU2004261373B8 (https=)
BR (1) BRPI0412891A (https=)
CA (1) CA2532718A1 (https=)
CO (1) CO5660292A2 (https=)
CR (1) CR8184A (https=)
CY (1) CY1106391T1 (https=)
DE (1) DE502004002570D1 (https=)
DK (1) DK1651618T3 (https=)
EA (1) EA010566B1 (https=)
EC (1) ECSP066278A (https=)
ES (1) ES2279395T3 (https=)
HR (1) HRP20070057T3 (https=)
IL (1) IL172848A0 (https=)
MA (1) MA27949A1 (https=)
MX (1) MXPA06000038A (https=)
NZ (1) NZ545103A (https=)
PE (1) PE20050882A1 (https=)
PL (1) PL1651618T3 (https=)
PT (1) PT1651618E (https=)
SI (1) SI1651618T1 (https=)
TW (1) TW200516075A (https=)
UY (1) UY28436A1 (https=)
WO (1) WO2005012261A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1768972A1 (de) * 2004-07-14 2007-04-04 Basf Aktiengesellschaft 2-substituierte pyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen
CL2007002231A1 (es) * 2006-08-02 2008-04-11 Basf Ag Uso de compuestos derivados de 5-(het) arilpirimidina para combatir hongos daninos; compuestos derivados de 5-(het) arilpirimidina; agente fungicida; y agente farmaceutico.
BR112013011868A2 (pt) * 2010-11-16 2016-08-23 Acetylon Pharmaceuticals Inc compostos de pirimidina hidróxi amida como inibidores da proteína desacetilase, composição farmacêutica e uso dos referidos compostos
ES2929576T3 (es) 2013-10-08 2022-11-30 Acetylon Pharmaceuticals Inc Combinaciones de inhibidores de histona deacetilasa 6 y el inhibidor de Her2 lapatinib para el uso en el tratamiento del cáncer de mama
WO2015054474A1 (en) 2013-10-10 2015-04-16 Acetylon Pharmaceuticals, Inc. Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors
US10660890B2 (en) 2013-10-24 2020-05-26 National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government Nih Division Of Extramural Inventions And Technology Resources (Deitr) Treatment of polycystic diseases with an HDAC6 inhibitor
CR20160308A (es) 2013-12-03 2016-11-08 Acetylon Pharmaceuticals Inc Combinaciones de inhibidores de histona deacetilasa y farmacos inmunomoduladores
US9464073B2 (en) 2014-02-26 2016-10-11 Acetylon Pharmaceuticals, Inc. Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors
SG11201700094TA (en) 2014-07-07 2017-02-27 Acetylon Pharmaceuticals Inc Treatment of leukemia with histone deacetylase inhibitors
US9937174B2 (en) 2014-12-05 2018-04-10 University of Modena and Reggio Emilia Combinations of histone deacetylase inhibitors and bendamustine
US10272084B2 (en) 2015-06-01 2019-04-30 Regenacy Pharmaceuticals, Llc Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy
EP3445364A4 (en) 2016-04-19 2019-11-27 Acetylon Pharmaceuticals, Inc. HDAC INHIBITORS, ONLY OR IN COMBINATION WITH BTK INHIBITORS, FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA
JP6976577B2 (ja) * 2016-07-20 2021-12-08 国立大学法人東北大学 PPARαアゴニストを含有する、肺高血圧症の予防又は治療剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE303367T1 (de) 2000-06-13 2005-09-15 5 phenyl substituierte 2-(cyanoamino)-pyrimidine als fungizide
WO2002074753A2 (de) 2001-03-15 2002-09-26 Basf Aktiengesellschaft 5-phenylpyrimidine, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung zur bekaempfung von schadpilzen
CA2467683C (en) 2001-11-19 2011-09-27 Basf Aktiengesellschaft 5-phenylpyrimidines, agents comprising the same, method for production and use thereof

Also Published As

Publication number Publication date
EA010566B1 (ru) 2008-10-30
CR8184A (es) 2006-10-06
PT1651618E (pt) 2007-03-30
PE20050882A1 (es) 2005-12-01
MXPA06000038A (es) 2006-03-21
DE502004002570D1 (de) 2007-02-15
ATE350370T1 (de) 2007-01-15
NZ545103A (en) 2008-06-30
DK1651618T3 (da) 2007-05-14
EA200600212A1 (ru) 2006-08-25
EP1651618A1 (de) 2006-05-03
AR045100A1 (es) 2005-10-12
WO2005012261A1 (de) 2005-02-10
CY1106391T1 (el) 2011-10-12
JP2006528603A (ja) 2006-12-21
AP2006003497A0 (en) 2006-02-28
TW200516075A (en) 2005-05-16
IL172848A0 (en) 2006-06-11
AP2157A (en) 2010-09-13
HRP20070057T3 (hr) 2007-07-31
SI1651618T1 (sl) 2007-06-30
US7375108B2 (en) 2008-05-20
AU2004261373A1 (en) 2005-02-10
CO5660292A2 (es) 2006-07-31
EP1651618B1 (de) 2007-01-03
PL1651618T3 (pl) 2007-05-31
CA2532718A1 (en) 2005-02-10
MA27949A1 (fr) 2006-06-01
UY28436A1 (es) 2005-02-28
BRPI0412891A (pt) 2006-10-03
KR20060052857A (ko) 2006-05-19
AU2004261373B2 (en) 2010-08-19
AU2004261373B8 (en) 2010-11-04
US20070105873A1 (en) 2007-05-10
ECSP066278A (es) 2006-07-28

Similar Documents

Publication Publication Date Title
ES2279395T3 (es) Pirimidinas 2-substituidas.
US7820647B2 (en) 2-substituted pyrimidines and their use as pesticides
CN100453535C (zh) 2-取代嘧啶
JP2008505957A (ja) 2−置換ピリミジン、その調製方法および有害菌類を防除するためのその使用
CN100425595C (zh) 2-取代的嘧啶
EP1592695A1 (de) Pyrimidine, verfahren zu deren herstellung sowie deren verwendung
EP1575958B1 (de) Fungizide triazolopyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen sowie sie enthaltende mittel
JP2006522045A (ja) 2−置換ピリミジン
WO2009019099A1 (en) Tetrasubstituted pyrimidine derivatives for controlling phytopathogenic fungi
ES2290777T3 (es) 6-(2-cloro-4-alcoxi-fenil)-triazolopirimidinas, procedimiento para su elaboracion y su empleo para la lucha contra los hongos nocivos, asi como agentes que los contengan.